Sebeck identified 36 former workers who served primarily from 1993 to 2011 and had been diagnosed with cancer, including himself. Of those, 11 had non-Hodgkin lymphoma; three had died. The Air Force ...

Epigenetic therapy boosted immunotherapy response in refractory natural killer/T-cell lymphoma by turning cold tumors hot.

Regulatory T cells, which calm overactive immune responses, could play a role in autoimmune conditions, HIV cure research and cancer immunotherapy.

“Although lobular breast cancer accounts for a little over 10% of all breast cancers, the sheer number of new diagnoses each year makes this disease important to understand,” said Angela Giaquinto, ...

Qualified healthcare or service organizations can use this page to order FREE bulk subscriptions of Smart + Strong publications. Please select the products you would like to order and then hit the ...

Key Takeaways Among 42,451 patients, 8.5% developed financial toxicity (a credit score below 600) after their diagnosis; an additional 3% were already in that category. Patients whose credit score ...

Health center leaders are building a coalition that “hopefully” will include the main stakeholders in the county’s health care system — community health centers, clinics, hospitals, doctors, health ...

Dr. Mark Farrugia of Roswell Park Comprehensive Cancer Center describes new approach to post-operative radiation therapy for NSCLC.

Here's a list of the approved drugs to treat prostate cancer. Click on any of the medications for more info on indications, dosing and side effects. Erleada is an androgen receptor inhibitor approved ...

On September 19, the Food and Drug Administration (FDA) approved Keytruda Qlex, an injectable formulation of the widely used immune checkpoint inhibitor pembrolizumab. The European Medicines Agency ...

Here's a list of the approved drugs to treat breast cancer. Click on any of the medications for more info on indications, dosing and side effects. Arimidex is an aromatase inhibitor approved for ...

How the new system will work is still being hammered out. Vaccine recommendations from states, medical societies, and other groups are likely to diverge, creating dueling guidance and requirements.